Development and stability of IL-17-secreting T cells
dc.contributor.advisor | Kaplan, Mark H. | |
dc.contributor.author | Glosson, Nicole L. | |
dc.contributor.other | Blum, Janice Sherry, 1957- | |
dc.contributor.other | Yu, Andy | |
dc.contributor.other | Harrington, Maureen A. | |
dc.date.accessioned | 2015-02-11T19:47:00Z | |
dc.date.available | 2015-06-02T09:30:37Z | |
dc.date.issued | 2014 | |
dc.degree.date | 2014 | en_US |
dc.degree.discipline | Department of Microbiology and Immunology | en |
dc.degree.grantor | Indiana University | en_US |
dc.degree.level | Ph.D. | en_US |
dc.description | Indiana University-Purdue University Indianapolis (IUPUI) | en_US |
dc.description.abstract | IL-17-producing T cells are critical to the development of pathogen and tumor immunity, but also contribute to the pathology of autoimmune diseases and allergic inflammation. CD8+ (Tc17) and CD4+ (Th17) IL-17-secreting T cells develop in response to a cytokine environment that activates Signal Transducer and Activator of Transcription (STAT) proteins, though the mechanisms underlying Tc17/Th17 development and stability are still unclear. In vivo, Tc17 cells clear vaccinia virus infection and acquire cytotoxic potential, that is independent of IL-17 production and the acquisition of IFN-γ-secreting potential, but partially dependent on Fas ligand, suggesting that Tc17-mediated vaccinia virus clearance is through cell killing independent of an acquired Tc1 phenotype. In contrast, memory Th cells and NKT cells display STAT4-dependent IL-23-induced IL-17 production that correlates with Il23r expression. IL-23 does not activate STAT4 nor do other STAT4-activating cytokines induce Il23r expression in these populations, suggesting a T cell-extrinsic role for STAT4 in mediating IL-23 responsiveness. Although IL-23 is important for the maintenance of IL-17-secreting T cells, it also promotes their instability, often resulting in a pathogenic Th1-like phenotype in vitro and in vivo. In vitro-derived Th17 cells are also flexible when cultured under polarizing conditions that promote Th2 or Th9 differentiation, adopting the respective effector programs, and decreasing IL-17 production. However, in models of allergic airway disease, Th17 cells do not secrete alternative cytokines nor adopt other effector programs, and remain stable IL-17-secretors. In contrast to Th1-biased pro-inflammatory environments that induce Th17 instability in vivo, during allergic inflammatory disease, Th17 cells are comparatively stable, and retain the potential to produce IL-17. Together these data document that the inflammatory environment has distinct effects on the stability of IL-17-secreting T cells in vivo. | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/5902 | |
dc.identifier.uri | http://dx.doi.org/10.7912/C2/1736 | |
dc.language.iso | en_US | en_US |
dc.subject | T cell, IL-17, Th17, Tc17, STAT4, Allergic Airway Disease | en_US |
dc.subject.lcsh | Autoimmune diseases -- Research -- Evaluation -- Analysis | en_US |
dc.subject.lcsh | Anti-inflammatory agents | en_US |
dc.subject.lcsh | Inflammation -- Immunological aspects | en_US |
dc.subject.lcsh | Respiratory allergy | en_US |
dc.subject.lcsh | T cells -- Immunology | en_US |
dc.subject.lcsh | Interleukins -- Immunology | en_US |
dc.subject.lcsh | Asthma -- Pathophysiology | en_US |
dc.subject.lcsh | Th1 cells -- Research | en_US |
dc.subject.lcsh | Th2 cells -- Research | en_US |
dc.subject.lcsh | Cellular immunity | en_US |
dc.subject.lcsh | Immune response -- Regulation | en_US |
dc.subject.lcsh | Cellular control mechanisms | en_US |
dc.title | Development and stability of IL-17-secreting T cells | en_US |
dc.type | Thesis | en |